Several nations in Europe have continued the vaccine rollout of British drugmaker AstraZeneca last Mar. 19, after drug regulator European Medicines Agency and the World Health Organization declared the vaccine’s safety.
Pertaining to incidents of blood clots and pulmonary embolisms after people’s inoculation, the EMA said that the AstraZeneca jab was not found to be associated with these complications. It did not, however, rule it out “definitively.”
The resumption of vaccine rollouts in countries like Italy, Germany and France comes as a relief to their authorities given the marked rise in infections observed across the globe.
In Germany, infections are “now clearly exponential”, according to Robert Koch Institute’s deputy chief, Lars Schaade. In France, the government has held off imposing strict lockdowns, opting for new, varied restrictions.
The pause on rollouts of the AstraZeneca vaccine has set back progress, necessitating Italy to double over 200,000 inoculations per day in order to hit their target of 80 million citizens vaccinated by September. Although these holdups were short-lived, health experts fear that it profoundly affected vaccine confidence in people, especially those who were already hesitant about it to begin with.
Among leaders who got the shot are British Prime Minister Boris Johnson, French PM Jean Castex, Slovenian president Borut Pahor, PM Janez Jansa as well as a governor of a German state.